Abstract:Background: Nano-Pulse Stimulation (NPS) therapy applies electric pulses in the nanosecond domain to initiate regulated cell death in the treated tissues. This nonthermal therapy has been used to treat a wide range of murine tumors and has been shown to activate the immune system to inhibit the growth of rechallenge tumors, as well as untreated, abscopal tumors when accompanied by the injection of immune system stimulants into the treated tumors. Clinical trials have begun using NPS to treat basal cell carcinoma and hepatocellular carcinoma. Methods: Murine tumors can be easily imaged when the tumor cells are injected intradermally so that they grow within the mouse skin. Pulling the skin over a translucent light post shines light through the skin and makes it easy to treat the tumor and identify the treatment zone. Results: Original research using murine tumor models is described, including melanoma, squamous cell carcinoma, lung carcinoma, breast carcinoma, and pancreatic carcinoma. The energy required to ablate these tumors has been determined with pancreatic carcinoma and lung carcinoma exhibiting 90% ablation with 240 mJ/mm3, lung carcinoma and squamous cell carcinoma requiring 360 mJ/mm3, and melanoma requiring 480 mJ/mm3. NPS therapy initiated a variable immune response indicated by the rejection of injected rechallenge tumor cells with melanoma and hepatocellular carcinoma exhibiting the strongest response and lung carcinoma, the weakest response. Following the original research data, a review of human clinical trials using NPS therapy is presented. Conclusions: NPS therapy offers a nonthermal, drug-free approach for oncology, which is limited only by applying energy to the tumor. This new immunogenic modality is just beginning to be applied in the clinic. The 87% efficacy of the first large clinical trial conducted by several medical personnel is impressive and indicates that NPS is an effective new modality for cancer treatment.

New Advances in Treatment of Skin Malignant Tumors with Nanosecond Pulsed Electric Field: A Literature Review.

Research Advances of Anti-Tumor Immune Response Induced by Pulse Electric Field Ablation

Prospect of Nanosecond Pulsed Electric Field in the Treatment of Melanoma

Nanosecond Pulsed Electric Fields As a Novel Drug Free Therapy for Breast Cancer: an in Vivo Study.

Application of Pulsed Electric Fields to Cancer Therapy

Histopathological Follow-Up by Tissue Micro-Array in a Survival Study after Melanoma Treated by Nanosecond Pulsed Electric Fields (Nspef)

Advances in Photodynamic Therapy Based on Nanotechnology and Its Application in Skin Cancer

Pathological Changes in Melanoma Induced by Multiple Nanosecond Pulsed Electric Fields Treatments and Possible Mechanism Analysis

Pulse width and intensity effects of pulsed electric fields on cancerous and normal skin cells

Nanosecond pulsed electric field inhibits cancer growth followed by alteration in expressions of NF-κB and Wnt/β-catenin signaling molecules.

Treatment Effect Assessment of A375 Cell Subcutaneous Transplantable Tumor in Nude Mouse with Nanosecond Pulsed Electric Fields

Research Progress in the Effect and Mechanism of Electric Field in Treating Tumors

Electricity‐Assisted Cancer Therapy: from Traditional Clinic Applications to Emerging Methods Integrated with Nanotechnologies

Application Prospect of Nanosecond Pulsed Electric Fields in Motor System

Nano-Pulse Stimulation Therapy in Oncology

Melanoma Morphology Change & Apoptosis Induced by Multiple Nanosecond Pulsed Electric Fields

Advancements in nanoparticle-based treatment approaches for skin cancer therapy

How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT

Recent Advances in Nanotechnology for the Treatment of Melanoma

Comparative Study Of Nanosecond Electric Fields In Vitro And In Vivo On Hepatocellular Carcinoma Indicate Macrophage Infiltration Contribute To Tumor Ablation In Vivo

Antitumor Effect and Immune Response of Nanosecond Pulsed Electric Fields in Pancreatic Cancer